James D. Clark's most recent trade in CVS Health Corp was a trade of 14,710 Common Stock (Restricted) done at an average price of $68.0 . Disclosure was reported to the exchange on April 1, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
CVS Health Corp | James D. Clark | SVP, Cont & Chief Acct Officer | Grant, award, or other acquisition of securities at price $ 67.98 per share. | 01 Apr 2025 | 14,710 | 24,707 | - | 68.0 | 999,986 | Common Stock (Restricted) |
CVS Health Corp | James D. Clark | SVP, Cont & Chief Acct Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 67.98 per share. | 01 Apr 2025 | 2,266 | 11,240 (0%) | 0% | 68.0 | 154,043 | Common Stock |
CVS Health Corp | James D. Clark | SVP, Cont & Chief Acct Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2025 | 7,513 | 0 | - | - | Stock Option | |
CVS Health Corp | James D. Clark | SVP, Cont & Chief Acct Officer | Sale of securities on an exchange or to another person at price $ 66.35 per share. | 05 Mar 2025 | 7,513 | 8,394 (0%) | 0% | 66.4 | 498,488 | Common Stock |
CVS Health Corp | James D. Clark | SVP, Cont & Chief Acct Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 62.21 per share. | 05 Mar 2025 | 7,513 | 15,907 (0%) | 0% | 62.2 | 467,384 | Common Stock |
CVS Health Corp | James D. Clark | SVP, Cont & Chief Acct Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 59.85 per share. | 30 Nov 2024 | 86 | 8,394 (0%) | 0% | 59.8 | 5,147 | Common Stock |
CVS Health Corp | James D. Clark | SVP, Cont & Chief Acct Officer | Grant, award, or other acquisition of securities at price $ 79.56 per share. | 01 Apr 2024 | 10,683 | 15,109 | - | 79.6 | 849,939 | Common Stock (Restricted) |
CVS Health Corp | James D. Clark | SVP, Cont & Chief Acct Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.56 per share. | 01 Apr 2024 | 1,892 | 9,592 (0%) | 0% | 79.6 | 150,528 | Common Stock |
CVS Health Corp | James D. Clark | SVP, Cont & Chief Acct Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.56 per share. | 01 Apr 2024 | 1,112 | 8,480 (0%) | 0% | 79.6 | 88,471 | Common Stock |
CVS Health Corp | James D. Clark | SVP, Cont & Chief Acct Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 2,452 | 7,150 (0%) | 0% | 0 | Common Stock | |
CVS Health Corp | Clark D. James | SVP, Cont & Chief Acct Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.48 per share. | 14 Dec 2023 | 122 | 8,760 | - | 68.5 | 8,355 | Common Stock (Restricted) |
CVS Health Corp | James D. Clark | SVP, Cont & Chief Acct Officer | Sale of securities on an exchange or to another person at price $ 74.94 per share. | 03 Aug 2023 | 23,128 | 4,698 (0%) | 0% | 74.9 | 1,733,212 | Common Stock |
CVS Health Corp | James D. Clark | SVP, Cont & Chief Acct Officer | Sale of securities on an exchange or to another person at price $ 74.80 per share. | 03 Aug 2023 | 2,631 | 27,826 (0%) | 0% | 74.8 | 196,792 | Common Stock |
CVS Health Corp | James D. Clark | SVP, Cont & Chief Acct Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2023 | 9,649 | 9,649 | - | - | Stock Option | |
CVS Health Corp | James D. Clark | SVP, Cont & Chief Acct Officer | Grant, award, or other acquisition of securities at price $ 74.31 per share. | 01 Apr 2023 | 2,186 | 9,080 | - | 74.3 | 162,442 | Common Stock (Restricted) |
CVS Health Corp | James D. Clark | SVP, Cont & Chief Acct Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.31 per share. | 01 Apr 2023 | 1,471 | 30,457 (0%) | 0% | 74.3 | 109,310 | Common Stock |
CVS Health Corp | James D. Clark | SVP, Cont & Chief Acct Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.54 per share. | 28 Feb 2023 | 179 | 26,151 (0%) | 0% | 83.5 | 14,954 | Common Stock |
CVS Health Corp | James D. Clark | SVP, Cont & Chief Acct Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.65 per share. | 01 Dec 2022 | 153 | 26,177 (0%) | 0% | 101.6 | 15,552 | Common Stock |
CVS Health Corp | James D. Clark | SVP, Cont & Chief Acct Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 6,756 | 6,756 | - | - | Stock Option | |
CVS Health Corp | James D. Clark | SVP, Cont & Chief Acct Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.09 per share. | 01 Apr 2022 | 3,897 | 29,070 (0%) | 0% | 101.1 | 393,948 | Common Stock |
CVS Health Corp | James D. Clark | SVP, Cont & Chief Acct Officer | Grant, award, or other acquisition of securities at price $ 101.09 per share. | 01 Apr 2022 | 3,214 | 12,824 | - | 101.1 | 324,903 | Common Stock (restricted) |
CVS Health Corp | James D. Clark | SVP, Cont & Chief Acct Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.09 per share. | 01 Apr 2022 | 2,740 | 26,330 (0%) | 0% | 101.1 | 276,987 | Common Stock |
CVS Health Corp | James D. Clark | SVP, Cont & Chief Acct Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 103.65 per share. | 28 Feb 2022 | 253 | 26,668 (0%) | 0% | 103.6 | 26,223 | Common Stock |
CVS Health Corp | James D. Clark | SVP, Cont & Chief Acct Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 103.65 per share. | 28 Feb 2022 | 183 | 26,334 (0%) | 0% | 103.7 | 18,968 | Common Stock |
CVS Health Corp | James D. Clark | SVP, Cont & Chief Acct Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2022 | 8,595 | 26,092 (0%) | 0% | 0 | Common Stock | |
CVS Health Corp | James D. Clark | SVP, Cont & Chief Acct Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jan 2022 | 6,059 | 0 | - | - | Stock Option | |
CVS Health Corp | James D. Clark | SVP, Cont & Chief Acct Officer | Sale of securities on an exchange or to another person at price $ 109.00 per share. | 28 Jan 2022 | 6,059 | 17,497 (0%) | 0% | 109 | 660,431 | Common Stock |
CVS Health Corp | James D. Clark | SVP, Cont & Chief Acct Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 102.26 per share. | 28 Jan 2022 | 6,059 | 23,556 (0%) | 0% | 102.3 | 619,593 | Common Stock |
CVS Health Corp | James D. Clark | SVP, Cont & Chief Acct Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 88.78 per share. | 01 Dec 2021 | 266 | 16,723 | - | 88.8 | 23,615 | Common Stock (restricted) |
CVS Health Corp | James D. Clark | SVP, Cont & Chief Acct Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.30 per share. | 03 Apr 2021 | 480 | 17,497 (0%) | 0% | 74.3 | 35,664 | Common Stock |
CVS Health Corp | James D. Clark | SVP, Cont & Chief Acct Officer | Sale of securities on an exchange or to another person at price $ 76.00 per share. | 31 Mar 2021 | 5,350 | 7,244 (0%) | 0% | 76 | 406,600 | Common Stock |
CVS Health Corp | James D. Clark | SVP, Cont & Chief Acct Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2021 | 5,350 | 0 | - | - | Stock Option | |
CVS Health Corp | James D. Clark | SVP, Cont & Chief Acct Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 74.29 per share. | 31 Mar 2021 | 5,350 | 12,594 (0%) | 0% | 74.3 | 397,452 | Common Stock |
CVS Health Corp | James D. Clark | SVP, Cont & Chief Acct Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.13 per share. | 28 Feb 2021 | 1,129 | 7,244 (0%) | 0% | 68.1 | 76,919 | Common Stock |
CVS Health Corp | James D. Clark | SVP, Cont & Chief Acct Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2021 | 13,113 | 17,930 (0%) | 0% | 0 | Common Stock | |
CVS Health Corp | James D. Clark | SVP, Cont & Chief Acct Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2021 | 12,094 | 12,094 | - | - | Stock Option | |
CVS Health Corp | James D. Clark | SVP, Cont & Chief Acct Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.30 per share. | 01 Feb 2021 | 5,246 | 15,111 (0%) | 0% | 74.3 | 389,778 | Common Stock |
CVS Health Corp | James D. Clark | SVP, Cont & Chief Acct Officer | Grant, award, or other acquisition of securities at price $ 74.30 per share. | 01 Feb 2021 | 4,710 | 18,046 (0%) | 0% | 74.3 | 349,953 | Common Stock (restricted) |
CVS Health Corp | James D. Clark | SVP, Cont & Chief Acct Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.30 per share. | 01 Feb 2021 | 1,503 | 16,920 (0%) | 0% | 74.3 | 111,673 | Common Stock |
CVS Health Corp | James D. Clark | SVP, Cont & Chief Acct Officer | Sale of securities on an exchange or to another person at price $ 65.00 per share. | 26 May 2020 | 270 | 4,547 (0%) | 0% | 65 | 17,550 | Common Stock |